Vivos Therapeutics, Inc. Fair Value Adjustment of Warrants
Vivos Therapeutics, Inc. (VVOS) reported Fair Value Adjustment of Warrants of -$10.23 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-03-31
- Vivos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-12-31 was $131.00K.
- Vivos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-09-30 was -$1.60M.
- Vivos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-06-30 was $867.00K.
- Vivos Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-03-31 was -$9.63M.
- Vivos Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was -$10.23M.
| Period end | Fair Value Adjustment of Warrants 0 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.47M derived: sum of 2 quarters · filed 2025-03-31 | -$602.00K derived: sum of 3 quarters · filed 2025-03-31 | -$10.23M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.60M 10-Q · filed 2024-11-14 | -$733.00K derived: sum of 2 quarters · filed 2024-11-14 | -$10.36M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $867.00K 10-Q · filed 2024-08-14 | -$8.76M 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | -$9.63M 10-Q · filed 2024-05-14 | ||||
| 2021-03-29 | $136.33K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |